Company Filing History:
Years Active: 2021
Title: Zhen Quan - Innovator in Molecular Imaging for Liver Regeneration
Introduction
Zhen Quan is a notable inventor based in Harbin, China. He has made significant contributions to the field of molecular imaging, particularly in evaluating liver regeneration capacity after ALPPS (Associating Liver Partition and Portal vein ligation for Staged hepatectomy) operations. His innovative approach has the potential to enhance clinical practices in liver surgery.
Latest Patents
Zhen Quan holds a patent for a molecular imaging method designed to assess liver regeneration ability following ALPPS. The patent outlines a comprehensive process that includes preparing a VX2 rabbit liver cancer model, performing ALPPS on this model, synthesizing 18F-Fluoromethylcholine (18F-Methylcholine, 18F-FCH), and conducting PET/CT imaging along with data processing. This method is groundbreaking as it is the first to utilize 18F-FCH PET/CT to monitor the proliferative capacity of residual liver tissue. The technique indirectly reflects the increased ability of cell membrane synthesis, providing a novel way to evaluate liver regeneration capacity after ALPPS.
Career Highlights
Zhen Quan is affiliated with Harbin Medical University, where he continues to advance his research in molecular imaging and liver regeneration. His work is pivotal in bridging the gap between innovative imaging techniques and practical clinical applications.
Collaborations
Zhen Quan collaborates with esteemed colleagues, including Xilin Sun and Ruifeng Wang, who contribute to his research endeavors and enhance the impact of his work in the medical field.
Conclusion
Zhen Quan's contributions to molecular imaging represent a significant advancement in evaluating liver regeneration after surgical procedures. His innovative methods provide valuable insights that can improve clinical outcomes for patients undergoing liver surgeries.